Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Händelser under helåret 2012Laquinimod fas III-data presenterade på AAN (64th Annual Meeting of the American Academy of Neurology) registreringsansökan inlämnad i EU, 5 MUSD i...
-
Events for the full year 2012Laquinimod Phase III data presented at the AAN (64th Annual Meeting of the American Academy of Neurology)Application submitted for regulatory approval in the EU,...
-
· Studiens primära mål - att uppvisa förlängd överlevnad i populationen ITT (intention to treat) - uppnåddes ej.· En subgruppsanalys av patienter med låga/normala nivåer av biomarkören IL-6 och...
-
· The primary endpoint - to show a survival advantage in the intention to treat (ITT) population - was not reached.· In a subgroup analysis, patients with low/normal baseline IL-6 and expected...
-
Lund den 3 januari 2013 - Active Biotech (NASDAQ OMX NORDIC: ACTI) kommer att presentera företaget på konferensen JP Morgan 31st Annual Healthcare Conference som hålls den 6-10 januari i San...
-
Lund, Sweden, January 3, 2013 - Active Biotech (NASDAQ OMX NORDIC: ACTI) is scheduled to present at the JP Morgan 31st Annual Healthcare Conference held January 6-10, 2013 in San Francisco, US....
-
Lund, Sverige, den 12 december, 2012 - Active Biotechs (NASDAQ OMX NORDIC: ACTI) samarbetspartner Teva Pharmaceutical Industries Ltd. höll igår, den 11 december 2012, ett investerarmöte. Teva har en...
-
Lund, Sweden, December 12, 2012 - Active Biotech's (NASDAQ OMX NORDIC: ACTI) partner Teva Pharmaceutical Industries Ltd. hosted yesterday, December 11, 2012, an investor meeting. Teva has a license...
-
Lund, Sverige, den 11 december, 2012 - Active Biotechs (NASDAQ OMX NORDIC: ACTI) samarbetspartner Teva Pharmaceutical Industries Ltd. kommer idag, tisdagen den 11 december 2012, kl.18.00 (12 p.m....
-
Lund, Sweden, December 11, 2012 - Active Biotech's (NASDAQ OMX NORDIC: ACTI) partner Teva Pharmaceutical Industries Ltd. will today Tuesday, December 11, 2012 at 12:00 p.m. ET (6:00 p.m. CET) host an...